One Up, One Down For Euro RSCG

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

It was good news, bad news for Havas’ Euro RSCG last week. Novartis selected Euro to handle an estimated $50 million global assignment for its Nicotinell smoking-cessation gum, sources said. But the shop also learned that its $15 million New Balance athletic-shoe creative account is going off the roster at year’s end.

On Nicotinell, Euro RSCG in New York will serve as lead agency, with help from its London office. The pharmaceutical and consumer-health company, based in Basil, Switzerland, markets Nicotinell throughout much of the world but is awaiting FDA approval for the drug in the U.S.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in